Abstract
Coronavirus disease 2019 (COVID-19) co-infection in patients with myasthenia gravis has not been well described. Our primary aim is to describe the course of illness of a myasthenia patient who developed repeated episodes of myasthenic crisis along with severe COVID-19 infection. This case highlights the need to monitor the immune response to the infection accurately, and treatment of myasthenia gravis with COVID-19 should be tailored to the individual patient.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 66-69 |
| Number of pages | 4 |
| Journal | Journal of Cellular and Molecular Anesthesia |
| Volume | 7 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2022 |
All Science Journal Classification (ASJC) codes
- Anesthesiology and Pain Medicine
- Pharmacology (medical)